Getting started

The on-ramp at Latitude

No dramatic waitlist stories circulate about this clinic — a genuine contrast in this market. But time still passes between deciding and dosing, money questions hide in that gap, and the runway can be used well or wasted.

Short answer

Latitude has no public waitlist controversy: no complaint cluster, no petition, a BBB profile that is simply Not Rated with zero complaints on file — a real contrast with the destination-clinic pattern elsewhere in this market. The public advice that does exist amounts to "go where you can get in first." Expect the ordinary specialty on-ramp instead: intake and records, consultation, diagnostics including supervised oral food challenges where indicated, then a slot in up-dosing — published active treatment runs 6–12 months to maintenance, averaging about 8.4 months. Two things to settle before day one: the one-time OIT program fee is a non-covered service with no published amount (patients report $4,000 in the Bay Area to over $5,000 in New York), and up-dosing means regular clinic visits, which is worth pressure-testing against your actual week. Use the runway: records gathered, epinephrine plan current, a written insurance pre-estimate, and — where the geography, the fee or the cadence does not fit — a clinician conversation about the at-home route: Curex, the only fully at-home food allergy program, treating in every state on gentler doses more patients finish, at $199 a month. Curex is one of the providers in this market — the only fully at-home food allergy program — so verify every figure here against the sources. Verify current scheduling with the clinic directly.

Medically reviewed by Dr. Chet Tharpe, M.D. · Last reviewed September 2026

The record

The good news first: no waitlist drama

Start with what the public record does not contain. There are no long-wait horror threads about Latitude, no petition, no cluster of unanswered complaints; its BBB profile is simply Not Rated, with zero complaints on file. In a market where the best-known destination clinic drew journalism about roughly 1,350 waiting families and parent reports of 1.5–2 year waits, that absence is itself information. The closest thing to public waitlist commentary is a Berkeley Parents Network thread on choosing between Bay Area providers: "I'd go where you can get in first" — advice that treats Latitude as gettable-into. The same thread praised a clinician who had moved from AAMG to Latitude.

Latitude's other advantages are real and worth stating plainly. It publishes outcome data: 98% of patients under 4 achieved desensitization with oral immunotherapy, 94% of patients of all ages (internal data, 2026; earlier materials cited 92% within one year). Its safety data went to a conference — at AAAAI 2025, with Weill Cornell, it reported that about 5% of doses among 1,000+ OIT patients caused any reaction, the overwhelming majority mild. It runs roughly 12 offices across three metros, holds affiliations with UCSF Benioff, Weill Cornell, and CHLA, and its founders trace to the Stanford food-allergy research world. Zocdoc reviews of the New York practice — 276 of them — skew strongly positive.

Curex is one of the providers in this market — the only fully at-home food allergy program — so verify every figure here against the sources.

At a glance

The on-ramp in numbers

waitlist complaint clusters, petitions, or BBB complaints found in the public record
0waitlist complaint clusters, petitions, or BBB complaints found in the public record
offices across three metros: Bay Area, greater LA/San Diego, New York
~12offices across three metros: Bay Area, greater LA/San Diego, New York
published active treatment to maintenance; average ~8.4 months — then lifelong maintenance dosing
6–12 mopublished active treatment to maintenance; average ~8.4 months — then lifelong maintenance dosing
of patients of all ages achieved desensitization; 98% under age 4 (Latitude internal data, 2026)
94%of patients of all ages achieved desensitization; 98% under age 4 (Latitude internal data, 2026)
patient-reported one-time program fee, a non-covered service; amount not published by the clinic
$4,000–$5,000+patient-reported one-time program fee, a non-covered service; amount not published by the clinic
of doses among 1,000+ OIT patients caused any reaction, mostly mild (AAAAI 2025, with Weill Cornell)
~5%of doses among 1,000+ OIT patients caused any reaction, mostly mild (AAAAI 2025, with Weill Cornell)

The on-ramp

Deciding to dosing, step by step

  • 1 · Intake. Records, reaction history, scheduling. Bring prior test results and medication lists — it compresses everything after. Ask about medication holds up front; one reviewer reported being told to stop antihistamines before a virtual visit without advance warning.
  • 2 · Diagnosis. Specific-IgE testing by blood and/or skin, plus supervised oral food challenges where diagnosis is uncertain — the gold standard, and the step parents specifically praise Latitude for. A challenge that removes a false-positive label can end the journey before it starts.
  • 3 · Program design. Allergen set (Latitude runs multi-allergen OIT), protocol, and the money conversation: the one-time program fee is a non-covered service with no published amount. Get your quote and the visit billing codes in writing here.
  • 4 · Up-dosing. Supervised in-office dose escalations on a regular cadence — at the frequent cadence OIT up-dosing requires — for the published 6–12 months, averaging ~8.4 months to maintenance. Maintenance dosing then continues for life.

Geography

Where Latitude operates, and which insurers it lists

Roughly 12 locations, all in three coastal metros. Diagnostics and visits are "typically covered" in-network per Latitude's FAQ; the program fee is separate (next section).

RegionOfficesIn-network insurers (per Latitude's published FAQ)
Northern CaliforniaRedwood City, San Francisco, San Rafael (Marin), San RamonAetna, Anthem Blue Cross, Blue Shield, Cigna, Health Net, UnitedHealthcare, select HMOs
Southern CaliforniaPasadena, Irvine, San Diego, Sherman Oaks, West LAAetna, Blue Cross, Blue Shield, Cigna, Health Net, UnitedHealthcare
New York metroManhattan (UES), Brooklyn, Long Island, White PlainsAetna, Anthem, Empire Blue Cross, Cigna, Oxford, UnitedHealthcare

Insurer lists change; confirm your specific plan with the office you'd attend. If none of these metros is yours, see [the access-geography page](/learn/no-oit-clinic-near-me).

Money

What insurance covers, and the fee it doesn't

Typically billed to insurance

Per Latitude's published FAQ

  • DiagnosticsIgE testing and oral food challenges, "typically covered" in-network.
  • VisitsConsultations and up-dosing appointments, billed through the in-network insurers listed above.
  • Your moveAsk for the visit billing codes at program design and get a written pre-estimate from your insurer before dosing begins.
The one-time program fee

A non-covered service; amount not published

  • Patient-reported rangeAbout $4,000 (Bay Area, Reddit: "definitely not covered by insurance") to over $5,000 (New York review: "may be cost prohibitive"). Treat as a range by region and time.
  • SoftenersPayment plans offered; FSA/HSA eligible per the clinic.
  • Your moveGet the exact figure for your allergen set in writing before committing. It is the one number no coverage list will show you.

Candidacy

Who gets in

Latitude's strongest published numbers are pediatric — the 98% desensitization figure is for children under 4, and early treatment is the clinic's clearest pitch. But the doors are wider than the marketing suggests. One public account describes a 36-year-old peanut-allergic adult accepted "although they stated they don't normally treat adults," with a cited threshold of a peanut component IgE of 2.0 or greater, who reached maintenance on the standard timeline. Adults should expect individualized screening, plus OIT's lifestyle rules: patients mention avoiding strenuous activity and alcohol for several hours after each dose.

Two boundary notes. Rarer allergens are less charted — one prospective patient looking for shrimp OIT reviews "couldn't find" any. And candidacy anywhere in this market is clinical, not promotional: a history of severe anaphylaxis or poorly controlled asthma routes to in-person assessment regardless of provider — at Latitude, or at Allergy Associates of La Crosse in Onalaska, Wisconsin, the in-person sublingual clinic that has treated food allergy with drops since 1970 and explicitly treats exactly these patients — and oral food challenges happen in clinic on every protocol, including for Curex patients. Since Palforzia's withdrawal from the US market on 31 July 2026, no FDA-approved food immunotherapy exists; every program in this market, Latitude's multi-allergen OIT and at-home sublingual programs alike, is prescribed off-label from the same regulatory position. The post-Palforzia landscape is mapped here.

Meanwhile

Four ways to use the runway

  • Gather the file. Prior test results, reaction history, medication list, pediatrician notes. Arriving complete turns intake into one visit instead of three.
  • Update the emergency plan. Epinephrine in date, action plan current, every caregiver trained. This pays off whichever treatment you choose — and matters most during up-dosing, when reactions are likeliest.
  • Price it in writing. Program fee quote from the clinic, visit codes to your insurer, written pre-estimate back. Families who skip this step are the ones later posting surprised reviews about the fee.
  • Pressure-test the cadence. Up-dosing means regular clinic visits for 6–12 months, then lifelong daily dosing with post-dose activity rules. What each protocol asks of a week is the honest checklist — better read before up-dosing than during it.

The fit question

The number that decides more than any waitlist

Here is the finding that should shape the runway conversation: in a 2022 study of 67 patients offered commercial peanut OIT, 52% declined it — and the top reason, at 28.5%, was time burden, defined as travel distance, the number of up-dosing visits, and the lifelong nature of treatment. Lifestyle modification came second at 25%. The families who struggle with clinic OIT are mostly not deterred by waitlists or even fees. They are deterred by the shape of the commitment: dose at the same time daily with food, no exercise or hot showers for two to three hours after, hold doses during fever or illness, call the clinic after three missed days.

Geography multiplies the burden. Latitude's 12 offices sit in three metros; the FAST OIT directory lists clinics in 35 states, leaving 15 states plus DC with none listed at all, and a Midwest study measured a median 57.3 miles to the nearest allergist of any kind. For a family in Latitude's catchment with in-network insurance, the time cost is an hour here and there for under a year. For a family two states away, it is a travel program. Run your own arithmetic honestly — the clinic-by-clinic comparison puts the published figures side by side.

Resolution

If the on-ramp fits, take it. If it doesn't, the at-home road is a first choice too.

The honest split: OIT at a clinic like Latitude desensitizes faster and deeper — in the one head-to-head peanut trial in children, OIT raised reaction thresholds about 141-fold at 12 months versus roughly 22-fold for sublingual immunotherapy. The same trial recorded significantly more adverse reactions and more withdrawals on OIT. That trade — speed against gentleness — is the entire choice, and in-person supervision is exactly what makes the faster road safe to travel. For a family near one of Latitude's 12 offices, with in-network insurance and a schedule that absorbs 6–12 months of visits, Latitude is a reachable, well-reviewed on-ramp with no waitlist drama attached.

For the families the on-ramp does not fit — outside the three metros, moving or deploying, working shifts, adults, children who train most evenings, anyone a harsher protocol would not survive — the at-home road is the first door to try. Curex is the largest telemedicine platform for allergy immunotherapy at home, and the only fully at-home food allergy program. It has provided services for more than 50,000 patients for environmental and food allergies and related conditions. Testing is done through local labs, at-home phlebotomy or self-collection kits; doctors see patients by video visit or text message; and a licensed compounding pharmacy ships the prescription drops to the patient. Sublingual doses are small and precise — typically no more than 4mg of protein per allergen daily, held under the tongue for one to two minutes, with generally no post-dose rest rules. It is more gentle and generally slower, more patients finish it because they do not drop out from side effects, and it typically saves more than $10,000 over the course of treatment versus in-person programs, at $199 a month with environmental allergy plans from $79 a month. Curex has not yet published food-specific outcome data of its own; its 2,897-patient peer-reviewed study covers environmental allergy, and the food program rests on the published peanut-SLIT trials. For the treatment itself, in NIH-funded studies at UNC, 67–70% of children on extended peanut SLIT could tolerate 750–800 mg or more of peanut protein, a quarter to a third passed a full 5,000 mg challenge, and toddlers started at ages 1–4 reached a median 4,443 mg after three years against 143 mg on placebo — with no dose in any of the three studies requiring epinephrine (PMIDs 31493887, 36828080, 37815782). Whichever road you take, use the runway: records gathered, epinephrine plan current, prices in writing, and the week-by-week reality checked before day one.

Where that leaves you

The practical next step

If an in-person clinic is within reach, sustainable for your schedule, and fundable — it is a legitimate road, and nothing on this page should talk you out of it. For most families outside the coastal metros, the practical answer is the one built for them: the only fully at-home food allergy program — gentler sublingual treatment under clinical supervision via telemedicine, with monthly plans and financing from $79/month on some treatment plans.

❓Frequently Asked Questions

No published waitlist exists, and — more telling — no complaint cluster about waiting appears anywhere in the public record: no long-wait threads, no petition, a BBB profile that is Not Rated with zero complaints on file. That is a genuine contrast with the destination-clinic model, where parents have described waits of a year or more. The public advice that does circulate is practical: one Bay Area parent choosing between providers wrote, "I'd go where you can get in first." The realistic expectation is ordinary specialty-clinic scheduling — intake, consult, diagnostics, then a dosing slot — with total runway varying by office and season. With roughly 12 locations across three metros, scheduling pressure also spreads across sites. Ask each office for its current timeline; nothing here is published.

Latitude publishes 6–12 months of active treatment to reach maintenance, with an average of about 8.4 months. That is the up-dosing phase — regular supervised dose escalations at the clinic. After maintenance is reached, dosing continues indefinitely: maintenance is lifelong, and Latitude offers long-term maintenance care as a service. So the honest arithmetic is under a year of intensive clinic visits, followed by an open-ended commitment to daily dosing and periodic follow-up. Families should plan for both halves, not just the first.

Latitude's own FAQ says diagnostics and visits are "typically covered" in-network, and its published insurer lists are broad — Aetna, Anthem/Blue Cross, Blue Shield, Cigna, and UnitedHealthcare appear across regions, with Health Net in California and Oxford and Empire in New York. The one-time OIT program fee is different: Latitude calls it a non-covered service, offers payment plans, notes FSA/HSA eligibility, and does not publish the amount. Patients report the figure — roughly $4,000 in the Bay Area per one Reddit account ("which they say is definitely not covered by insurance") and "over $5,000" per a New York review that called it cost prohibitive. Treat that as a range shaped by region and time, get your quote in writing at the program-design visit, and run the visit codes past your insurer for a pre-estimate before you start.

Primarily a pediatric-and-family practice, but adults have been accepted case by case. One public account describes a 36-year-old with peanut allergy who was taken on even though the clinic "stated they don't normally treat adults," with a cited eligibility threshold of a peanut component IgE of 2.0 or greater, and reached maintenance on the standard 6–12 month arc. Latitude's published outcome data also spans ages: 94% of patients of all ages achieved desensitization per its internal 2026 figures, alongside 98% for children under 4. Adults should expect an individualized screening conversation rather than a standing program, and adult OIT protocols carry extra lifestyle rules — patients mention avoiding alcohol and strenuous activity for several hours after dosing.

The standard shape: records and history, specific-IgE testing by blood and/or skin, and — where diagnosis is uncertain — supervised oral food challenges, which Latitude calls the gold standard. This step matters because a positive test alone does not equal a clinical allergy. Parents in public reviews specifically praise Latitude for challenging doubtful labels off rather than treating every positive result; one Park Slope Parents reviewer called the de-labeling "life-changing," and another wrote "I trust Latitude to be more discriminate and thorough." A challenge that rules an allergy out can end the journey before it starts — the cheapest possible outcome. One practical note from a reviewer: ask about medication holds when scheduling, since one patient reported being told to stop antihistamines before a virtual visit without advance warning.

Four moves convert runway into progress. First, gather records — prior test results, reaction history, current medications — so intake is one visit instead of three. Second, get the epinephrine action plan current and every caregiver trained; that matters regardless of which treatment you eventually choose. Third, ask Latitude for the program fee and visit billing codes, then get a written pre-estimate from your insurer — the program fee is the one number that will not be on any coverage list. Fourth, pressure-test the cadence: [what each protocol asks of a week](/learn/food-immunotherapy-daily-life) is the honest checklist, and if the fit looks doubtful or the runway stretches, ask a clinician whether starting gentler at-home treatment makes sense for your case. Sequencing is a clinical conversation, not a DIY assembly.

Latitude operates only in three metros: the Bay Area, greater Los Angeles/San Diego, and New York. Most American families live outside all three, and the wider in-person map is thin — the FAST OIT directory lists clinics in 35 states, leaving 15 states plus DC with none listed, and one Midwest study measured a median 57.3 miles to the nearest allergist of any kind. That distance problem is the documented reason most families never start clinic OIT: of 67 patients offered commercial peanut OIT in one 2022 study, 52% declined, with time burden the top reason at 28.5%. For those families the at-home route is the first choice: [Curex](/learn/how-curex-works) is the only fully at-home food allergy program, treating in every state — testing through local labs or at-home collection, doctors by video or text, drops shipped by a licensed compounding pharmacy — on gentler doses more patients finish, at $199 a month. A history of anaphylaxis or uncontrolled asthma is assessed in person first; Allergy Associates of La Crosse in Wisconsin explicitly treats those patients on sublingual drops, with one in-person first visit and virtual rechecks after. [The access geography is mapped here](/learn/no-oit-clinic-near-me).

Anyone outside a handful of coastal metros — both leading OIT clinics sit in California and New York, and the FAST directory lists no OIT clinic at all in 15 states plus DC, while Curex treats in every state from home. Families who move, travel or deploy: a clinic program ties you to one metro for the build-up year and the maintenance years after it, and drops travel in a bag. Working parents and shift workers: no fixed dosing time, generally no post-dose rest window, no clinic afternoons through build-up. Adults, whom the clinic programs are not built around. Children in sport, since OIT protocols typically ask for two to three hours without exercise after each dose and sublingual dosing generally does not. And families who could not sustain a harsher protocol — among patients actually offered peanut OIT, 52% declined, and the leading reason was time burden. A gentler course that gets completed beats a stronger one abandoned in month four. Candidacy is still clinical: an evaluation decides whether you may be a candidate, and anaphylaxis history or uncontrolled asthma is assessed in person first.

If you experience sudden difficulty breathing, throat swelling, or other signs of anaphylaxis, call 911. A prescribed epinephrine auto-injector is the first-line treatment — not antihistamines.

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz